Dynamics of biosimilar uptake in emerging markets-Reference-Cited by-同舟云学术

Dynamics of biosimilar uptake in emerging markets

Published:2022-05-22 Issue:6 Volume:22 Page:679-688
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Chhabra Hemlata¹,Mouslim Morgane C²,Kashiramka Smita³,Rathore Anurag S¹^ORCID

Affiliation:

1. Department of Chemical Engineering, Indian Institute of Technology, Delhi, India

2. The Hilltop Institute, University of Maryland Baltimore County, Baltimore, USA

3. Department of Management Studies, Indian Institute of Technology, Delhi, India

Funder

Department of Biotechnology, Ministry of Science and Technology

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2022.2076557

Reference85 articles.

1. WHO. Towards access 2030 WHO medicines and health products programme strategic framework 2016-2030. World Health Organization 2017. Available from: https://www.who.int/medicines/publications/Towards_Access_2030_Final.pdf. cited1Dec 2021.

2. The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects

3. Linker R. Biosimilars market by product, manufacturing & indication, region – global forecast to 2025. 2020. Available from: https://www.reportlinker.com/p04604343/Biosimilars-Market-by-Product-Manufacturing-Application-Global-Forecast-to.html?utm_source=GNW. Accessed 2020 Sep 11.

4. Chen Y, Lehmann A, Santos da Silva J What’s next for biosimilars in emerging markets? McKinsey & company 2019. Available from https://www.mckinsey.com/industries/life-sciences/our-insights/whats-next-for-biosimilars-in-emerging-markets. cited 2021 Dec 1.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Global outlook on affordability of biotherapeutic drugs;Annals of the New York Academy of Sciences;2024-06-13

4. Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?;Frontiers in Public Health;2023-08-03

5. Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?;Biotechnology and Bioengineering;2022-09-28